TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,230 | -65.6% | 71,439 | +2.3% | 0.00% | -100.0% |
| Q2 2023 | $1,733,956 | +112.6% | 69,805 | +28.7% | 0.00% | – |
| Q1 2023 | $815,755 | +32.5% | 54,239 | +4.2% | 0.00% | – |
| Q4 2022 | $615,645 | +107.0% | 52,041 | +3.6% | 0.00% | – |
| Q3 2022 | $297,456 | +33.4% | 50,246 | -4.2% | 0.00% | – |
| Q2 2022 | $223,010 | -54.2% | 52,473 | +2.5% | 0.00% | – |
| Q1 2022 | $486,969 | -59.6% | 51,206 | -19.3% | 0.00% | -100.0% |
| Q4 2021 | $1,205,000 | -42.8% | 63,416 | +0.2% | 0.00% | -50.0% |
| Q3 2021 | $2,107,000 | -21.7% | 63,321 | -8.7% | 0.00% | 0.0% |
| Q2 2021 | $2,692,000 | -15.1% | 69,390 | +5.5% | 0.00% | -33.3% |
| Q1 2021 | $3,171,000 | -8.1% | 65,780 | -0.8% | 0.00% | 0.0% |
| Q4 2020 | $3,449,000 | +110.6% | 66,294 | +8.3% | 0.00% | +50.0% |
| Q3 2020 | $1,638,000 | +59.0% | 61,225 | +10.5% | 0.00% | +100.0% |
| Q2 2020 | $1,030,000 | +98.1% | 55,430 | +4.8% | 0.00% | 0.0% |
| Q1 2020 | $520,000 | -1.3% | 52,891 | +11.3% | 0.00% | 0.0% |
| Q4 2019 | $527,000 | +90.9% | 47,506 | -2.7% | 0.00% | – |
| Q3 2019 | $276,000 | -33.2% | 48,848 | +2.3% | 0.00% | – |
| Q2 2019 | $413,000 | +27.5% | 47,756 | +18.4% | 0.00% | – |
| Q1 2019 | $324,000 | +96.4% | 40,320 | -0.2% | 0.00% | – |
| Q4 2018 | $165,000 | -28.3% | 40,389 | -1.7% | 0.00% | – |
| Q3 2018 | $230,000 | -59.3% | 41,107 | -4.3% | 0.00% | -100.0% |
| Q2 2018 | $565,000 | +8.2% | 42,963 | +16.8% | 0.00% | 0.0% |
| Q1 2018 | $522,000 | +64.2% | 36,779 | -5.1% | 0.00% | – |
| Q4 2017 | $318,000 | -26.2% | 38,756 | +6.5% | 0.00% | -100.0% |
| Q3 2017 | $431,000 | +16.5% | 36,397 | -1.0% | 0.00% | – |
| Q2 2017 | $370,000 | +8.8% | 36,754 | +26.2% | 0.00% | – |
| Q1 2017 | $340,000 | +165.6% | 29,124 | +5.9% | 0.00% | – |
| Q4 2016 | $128,000 | -35.7% | 27,501 | +7.2% | 0.00% | – |
| Q3 2016 | $199,000 | +25.2% | 25,664 | -2.1% | 0.00% | – |
| Q2 2016 | $159,000 | -21.7% | 26,221 | +13.2% | 0.00% | – |
| Q1 2016 | $203,000 | -25.9% | 23,168 | +1.0% | 0.00% | – |
| Q4 2015 | $274,000 | +21.2% | 22,944 | +2.2% | 0.00% | – |
| Q3 2015 | $226,000 | -38.3% | 22,460 | +1.7% | 0.00% | – |
| Q2 2015 | $366,000 | +34.6% | 22,077 | +25.5% | 0.00% | – |
| Q1 2015 | $272,000 | +9.7% | 17,588 | +12.5% | 0.00% | – |
| Q4 2014 | $248,000 | +54.0% | 15,636 | +3.9% | 0.00% | – |
| Q3 2014 | $161,000 | +11.0% | 15,050 | -2.8% | 0.00% | – |
| Q2 2014 | $145,000 | +163.6% | 15,486 | +96.1% | 0.00% | – |
| Q1 2014 | $55,000 | – | 7,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |